Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gynecology

  Free Subscription


15.10.2018

6 Acta Obstet Gynecol Scand
4 Am J Obstet Gynecol
1 Ann Oncol
6 Aust N Z J Obstet Gynaecol
2 BMC Cancer
2 Br J Cancer
1 Br J Radiol
1 Cancer
4 Diagn Cytopathol
13 Eur J Obstet Gynecol Reprod Biol
1 Fertil Steril
3 Gynecol Endocrinol
7 Gynecol Oncol
8 Hum Reprod
2 Int J Cancer
14 Int J Gynaecol Obstet
5 JAMA
1 Lancet
3 Lancet Oncol
2 Lancet Public Health
18 Obstet Gynecol
3 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. CUERVA MJ, Garcia-Casarrubios P, Garcia-Calvo L, Gutierrez-Simon M, et al
    Use of intrapartum ultrasound in term pregnant women with contractions before hospital admission.
    Acta Obstet Gynecol Scand. 2018 Oct 4. doi: 10.1111/aogs.13474.
    PubMed     Text format     Abstract available

  2. MARTIMUCCI K, Bilinski R, Perez AM, Kuhn T, et al
    Interpregnancy interval and abnormally invasive placentation.
    Acta Obstet Gynecol Scand. 2018 Oct 4. doi: 10.1111/aogs.13478.
    PubMed     Text format     Abstract available

  3. SOLHEIM O, Skalleberg J, Warncke T, Orstavik K, et al
    Long-term neurotoxicity and raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor.
    Acta Obstet Gynecol Scand. 2018 Oct 5. doi: 10.1111/aogs.13477.
    PubMed     Text format     Abstract available

  4. ORABONA R, Prefumo F, Zanardini C, Magri R, et al
    Maternal functional hemodynamics in uncomplicated twin pregnancies: a longitudinal study using impedance cardiography.
    Acta Obstet Gynecol Scand. 2018 Oct 5. doi: 10.1111/aogs.13479.
    PubMed     Text format     Abstract available

  5. SODERMAN L, Edlund M, Marions L
    Prevalence and impact of dysmenorrhea in Swedish adolescents.
    Acta Obstet Gynecol Scand. 2018 Oct 12. doi: 10.1111/aogs.13480.
    PubMed     Text format     Abstract available

  6. RAHMAWATI E, Yang WV, Lei YP, Maurya PK, et al
    Gonadotropin-releasing hormone agonist induces downregulation of tensin 1 in women with endometriosis.
    Acta Obstet Gynecol Scand. 2018 Oct 12. doi: 10.1111/aogs.13481.
    PubMed     Text format     Abstract available


    Am J Obstet Gynecol

  7. GIBBS I, Leavey K, Benton SJ, Grynspan D, et al
    Placental Transcriptional and Histological Subtypes of Normotensive Fetal Growth Restriction are Comparable to Preeclampsia.
    Am J Obstet Gynecol. 2018 Oct 9. pii: S0002-9378(18)30872.
    PubMed     Text format     Abstract available

  8. DOLL K, Khor S, Odem-Davis K, He H, et al
    Role of Bleeding Recognition and Evaluation in Black-White Disparities in Endometrial Cancer.
    Am J Obstet Gynecol. 2018 Oct 3. pii: S0002-9378(18)30832.
    PubMed     Text format     Abstract available

  9. YU O, Scholes D, Schulze-Rath R, Grafton J, et al
    A US Population-based Study of Uterine Fibroid Diagnosis Incidence, Trends, and Prevalence: 2005-2014.
    Am J Obstet Gynecol. 2018 Oct 3. pii: S0002-9378(18)30831.
    PubMed     Text format     Abstract available

  10. WILSON LF, Pandeya N, Byles J, Mishra GD, et al
    Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
    Am J Obstet Gynecol. 2018 Oct 9. pii: S0002-9378(18)30871.
    PubMed     Text format     Abstract available


    Ann Oncol

  11. LEDERMANN JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, et al
    Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2018;29.
    PubMed     Text format    


    Aust N Z J Obstet Gynaecol

  12. COORAY SD, Langston-Cox AG, Robinson PJ, Bahemia N, et al
    Awareness and use of iodine supplementation among Australian women attending a low-risk pregnancy clinic.
    Aust N Z J Obstet Gynaecol. 2018;58:E16-E17.
    PubMed     Text format    

  13. LYNCH M, De Abreu Lourenco R, Flattery M, Haas M, et al
    Reviewing the cost-effectiveness of long-acting reversible contraceptive methods in an Australian context.
    Aust N Z J Obstet Gynaecol. 2018 Oct 12. doi: 10.1111/ajo.12906.
    PubMed     Text format     Abstract available

  14. SYMONDS I
    A common medical schools curriculum in obstetrics and gynaecology.
    Aust N Z J Obstet Gynaecol. 2018;58:491-493.
    PubMed     Text format    

  15. JAYAWARDENA L, Sheehan P
    Introduction of a customised growth chart protocol increased detection of small for gestational age pregnancies in a tertiary Melbourne hospital.
    Aust N Z J Obstet Gynaecol. 2018 Oct 9. doi: 10.1111/ajo.12902.
    PubMed     Text format     Abstract available

  16. LEVIN G, Rottenstreich A
    Re: Efficacy, feasibility and patient acceptability of ultrasound-guided manual vacuum aspiration for treating early pregnancy loss.
    Aust N Z J Obstet Gynaecol. 2018;58:E13.
    PubMed     Text format    

  17. CHUNG JPW, Li TC
    Reply to Re: 'Efficacy, feasibility and patient acceptability of ultrasound-guided manual vacuum aspiration for treating early pregnancy loss'.
    Aust N Z J Obstet Gynaecol. 2018;58:E14.
    PubMed     Text format    


    BMC Cancer

  18. MCGRATH SE, Annels N, Madhuri TK, Tailor A, et al
    Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
    BMC Cancer. 2018;18:943.
    PubMed     Text format     Abstract available

  19. BRUNETTE LL, Mhawech-Fauceglia PY, Ji L, Skeate JG, et al
    Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    BMC Cancer. 2018;18:970.
    PubMed     Text format     Abstract available


    Br J Cancer

  20. WANG P, Magdolen V, Seidl C, Dorn J, et al
    Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
    Br J Cancer. 2018 Oct 5. pii: 10.1038/s41416-018-0260.
    PubMed     Text format     Abstract available

  21. NIEMI RJ, Braicu EI, Kulbe H, Koistinen KM, et al
    Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism.
    Br J Cancer. 2018 Oct 8. pii: 10.1038/s41416-018-0270.
    PubMed     Text format     Abstract available


    Br J Radiol

  22. DJEFFAL H, Blouet M, Pizzoferrato AC, Vardon D, et al
    Imaging findings in essure related complications.
    Br J Radiol. 2018 Jun 21:20170686. doi: 10.1259/bjr.20170686.
    PubMed     Text format     Abstract available


    Cancer

  23. CHLEBOWSKI RT, Luo J, Anderson GL, Barrington W, et al
    Weight loss and breast cancer incidence in postmenopausal women.
    Cancer. 2018 Oct 8. doi: 10.1002/cncr.31687.
    PubMed     Text format     Abstract available


    Diagn Cytopathol

  24. POLANCO JACOME EC, Maerki J, Chau K, Akerman M, et al
    Lack of transformation zone in cervical Pap tests, should it be a concern? A quality assurance initiative.
    Diagn Cytopathol. 2018;46:584-588.
    PubMed     Text format     Abstract available

  25. DIAZ DEL ARCO C, Fernandez Acenero MJ
    Molecular diagnostic techniques in cytopathology: From the bench to the patient's bedside.
    Diagn Cytopathol. 2018;46:620-623.
    PubMed     Text format     Abstract available

  26. TOYODA S, Okada H, Tsujino H, Takeda Y, et al
    Postoperative cytological findings from the use of the Integran microfibrillar collagen hemostatic matrix in conization.
    Diagn Cytopathol. 2018;46:624-626.
    PubMed     Text format     Abstract available

  27. CHORNY JA, Frye TC, Fisher BL, Remmers CL, et al
    Human papillomavirus detection with genotyping by the cobas and Aptima assays: Significant differences in HPV 16 detection?
    Diagn Cytopathol. 2018;46:568-571.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  28. PARAZZINI F, Frattaruolo MP, Chiaffarino F, Dridi D, et al
    The limited oncogenic potential of unilocular adnexal cysts: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:101-109.
    PubMed     Text format     Abstract available

  29. BRAAM SC, de Bruin JP, Buisman ETIA, Brandes M, et al
    Treatment strategies and cumulative live birth rates in WHO-II ovulation disorders.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:84-89.
    PubMed     Text format     Abstract available

  30. MONTERA R, Scaletta G, Plotti F, Lopez S, et al
    The role of macroplastique implantation in the management of occult urinary stress incontinence.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:124-128.
    PubMed     Text format     Abstract available

  31. DICITORE A, Castiglioni S, Saronni D, Gentilini D, et al
    Effects of human recombinant type I IFNs (IFN-alpha2b and IFN-beta1a) on growth and migration of primary endometrial stromal cells from women with deeply infiltrating endometriosis: A preliminary study.
    Eur J Obstet Gynecol Reprod Biol. 2018;230:192-198.
    PubMed     Text format     Abstract available

  32. ALBERICO D, Somigliana E, Bracco B, Dhouha D, et al
    Potential benefits of pregnancy on endometriosis symptoms.
    Eur J Obstet Gynecol Reprod Biol. 2018;230:182-187.
    PubMed     Text format     Abstract available

  33. ALLEGRE L, Aristizabal P, Nyangoh Timoh K, Thomassin-Naggara I, et al
    Comparison of 3-Tesla to 1.5-Tesla Magnetic Resonance Enterography to assess multifocal and multicentric bowel endometriosis: Results in routine practice.
    Eur J Obstet Gynecol Reprod Biol. 2018;230:172-177.
    PubMed     Text format     Abstract available

  34. MARLEEN S, Hettiarachchi J, Dandeniya R, Macgreggor R, et al
    Maternal clinical predictors of preterm birth in twin pregnancies: A systematic review involving 2,930,958 twin pregnancies.
    Eur J Obstet Gynecol Reprod Biol. 2018;230:159-171.
    PubMed     Text format     Abstract available

  35. OUCHI M, Kitta T, Kanno Y, Moriya K, et al
    Medium-term follow-up after supervised pelvic floor muscle training for patients with anterior vaginal wall prolapse.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:95-100.
    PubMed     Text format     Abstract available

  36. PRODROMIDOU A, Vorgias G, Bakogiannis K, Kalinoglou N, et al
    MELF pattern of myometrial invasion and role in possible endometrial cancer diagnostic pathway: A systematic review of the literature.
    Eur J Obstet Gynecol Reprod Biol. 2018;230:147-152.
    PubMed     Text format     Abstract available

  37. BONDE L, Puschl IC, Moller LA, Ottesen B, et al
    No evidence of association between native tissue vault suspension and risk of pelvic pain or sexual dysfunction.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:141-147.
    PubMed     Text format     Abstract available

  38. ALSON SSE, Bungum LJ, Giwercman A, Henic E, et al
    Anti-mullerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-mullerian hormone is modest.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:199-204.
    PubMed     Text format     Abstract available

  39. BALZARRO M, Rubilotta E, Braga A, Bassi S, et al
    OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:228-231.
    PubMed     Text format     Abstract available

  40. TAGLIAFERRI V, Ricciardi L, Ricciardi R, Pinto LR, et al
    Carbon dioxide in office diagnostic hysteroscopy: An open question. A multicenter randomized trial on 1982 procedures.
    Eur J Obstet Gynecol Reprod Biol. 2018 Sep 28. pii: S0301-2115(18)31007.
    PubMed     Text format     Abstract available


    Fertil Steril

  41. DOMAR AD
    Quality of life must be taken into account when assessing the efficacy of infertility treatment.
    Fertil Steril. 2018;109:71-72.
    PubMed     Text format    


    Gynecol Endocrinol

  42. XU Z, Meng L, Pan C, Chen X, et al
    Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
    Gynecol Endocrinol. 2018 Oct 10:1-4. doi: 10.1080/09513590.2018.1500535.
    PubMed     Text format     Abstract available

  43. ASLFALAH H, Jamilian M, Khosrowbeygi A
    Elevation of the adiponectin/leptin ratio in women with gestational diabetes mellitus after supplementation with alpha-lipoic acid.
    Gynecol Endocrinol. 2018 Oct 10:1-5. doi: 10.1080/09513590.2018.1519795.
    PubMed     Text format     Abstract available

  44. ANIK ILHAN G, Yildizhan B, Pekin T
    The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2018 Oct 10:1-4. doi: 10.1080/09513590.2018.1519794.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  45. BELUR NAGARAJ A, Joseph P, Kovalenko O, Wang Q, et al
    Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
    Gynecol Oncol. 2018 Oct 6. pii: S0090-8258(18)31238.
    PubMed     Text format     Abstract available

  46. ELNAGGAR AC, Hade EM, O'Malley DM, Liang MI, et al
    Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
    Gynecol Oncol. 2018 Sep 30. pii: S0090-8258(18)31233.
    PubMed     Text format     Abstract available

  47. ALOISI A, Casanova JM, Tseng JH, Seader KA, et al
    Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment.
    Gynecol Oncol. 2018 Oct 1. pii: S0090-8258(18)31240.
    PubMed     Text format     Abstract available

  48. RASH JK, Lyle KD, Jairam-Thodla A, Ioffe Y, et al
    Delivery of gynecologic oncology care: Optimizing scope of advanced practice providers to enhance patient care: A Society of Gynecologic Oncology Position Paper.
    Gynecol Oncol. 2018 Oct 4. pii: S0090-8258(18)31237.
    PubMed     Text format    

  49. WANG J, Dean DC, Hornicek FJ, Shi H, et al
    RNA sequencing (RNA-Seq) and its application in ovarian cancer.
    Gynecol Oncol. 2018 Oct 5. pii: S0090-8258(18)31283.
    PubMed     Text format     Abstract available

  50. MONK BJ, Kauderer JT, Moxley KM, Bonebrake AJ, et al
    A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study.
    Gynecol Oncol. 2018 Oct 8. pii: S0090-8258(18)31281.
    PubMed     Text format     Abstract available

  51. NAUMANN RW, Morris JC, Tait DL, Higgins RV, et al
    Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer.
    Gynecol Oncol. 2018 Oct 8. pii: S0090-8258(18)31282.
    PubMed     Text format     Abstract available


    Hum Reprod

  52. CUI D, Sui L, Han X, Zhang M, et al
    Aquaporin-3 mediates ovarian steroid hormone-induced motility of endometrial epithelial cells.
    Hum Reprod. 2018 Oct 4. pii: 5115484. doi: 10.1093.
    PubMed     Text format     Abstract available

  53. LOY SL, Cheung YB, Soh SE, Ng S, et al
    Female adiposity and time-to-pregnancy: a multiethnic prospective cohort.
    Hum Reprod. 2018 Oct 4. pii: 5115481. doi: 10.1093.
    PubMed     Text format     Abstract available

  54. PAPAIKONOMOU K, Kopp Kallner H, Soderdahl F, Gemzell-Danielsson K, et al
    Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
    Hum Reprod. 2018 Oct 8. pii: 5123527. doi: 10.1093.
    PubMed     Text format     Abstract available

  55. SUHORUTSHENKO M, Kukushkina V, Velthut-Meikas A, Altmae S, et al
    Endometrial receptivity revisited: endometrial transcriptome adjusted for tissue cellular heterogeneity.
    Hum Reprod. 2018 Oct 8. pii: 5123535. doi: 10.1093.
    PubMed     Text format     Abstract available

  56. CANDIANI M, Ottolina J, Posadzka E, Ferrari S, et al
    Assessment of ovarian reserve after cystectomy versus 'one-step' laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial.
    Hum Reprod. 2018 Oct 9. pii: 5123813. doi: 10.1093.
    PubMed     Text format     Abstract available

  57. FARAG S, Frazzini Padilla P, Smith KA, Flyckt R, et al
    Fallopian tube perfusion in ex-vivo and in-vivo laparoscopic hysterectomy specimens: potential application for uterine transplantation.
    Hum Reprod. 2018 Oct 10. pii: 5125952. doi: 10.1093.
    PubMed     Text format     Abstract available

  58. HUANG K, Dang Y, Zhang P, Shen C, et al
    CAV1 regulates primordial follicle formation via the Notch2 signalling pathway and is associated with premature ovarian insufficiency in humans.
    Hum Reprod. 2018 Oct 9. pii: 5124569. doi: 10.1093.
    PubMed     Text format     Abstract available

  59. GRIESINGER G, Blockeel C, T Sukhikh G, Patki A, et al
    Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
    Hum Reprod. 2018 Oct 10. pii: 5125950. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Cancer

  60. MACKINTOSH ML, Derbyshire AE, McVey RJ, Bolton J, et al
    The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk.
    Int J Cancer. 2018 Oct 5. doi: 10.1002/ijc.31913.
    PubMed     Text format     Abstract available

  61. RASMUSSEN CL, Sand FL, Hoffmann Frederiksen M, Andersen KK, et al
    Does HPV status influence survival after vulvar cancer?
    Int J Cancer. 2017 Nov 1. doi: 10.1002/ijc.31139.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet


  62. Abstracts of the XXII FIGO World Congress of Gynecology & Obstetrics.
    Int J Gynaecol Obstet. 2018;143 Suppl 3:43-991.
    PubMed     Text format    

  63. SANCHEZ-FERRER ML, Jimenez-Velazquez R, Mendiola J, Prieto-Sanchez MT, et al
    Accuracy of anogenital distance and anti-Mullerian hormone in the diagnosis of endometriosis without surgery.
    Int J Gynaecol Obstet. 2018 Oct 9. doi: 10.1002/ijgo.12691.
    PubMed     Text format     Abstract available

  64. HIROSE A, Alwy F, Atuhairwe S, Morris JL, et al
    Disentangling the contributions of maternal and fetal factors to estimate stillbirth risks for intrapartum adverse events in Tanzania and Uganda.
    Int J Gynaecol Obstet. 2018 Oct 5. doi: 10.1002/ijgo.12689.
    PubMed     Text format     Abstract available

  65. BASU P, Mukhopadhyay A, Konishi I
    Targeted therapy for gynecologic cancers: Toward the era of precision medicine.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:131-136.
    PubMed     Text format     Abstract available

  66. MBATANI N, Olawaiye AB, Prat J
    Uterine sarcomas.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:51-58.
    PubMed     Text format     Abstract available

  67. BOA R, Grenman S
    Psychosexual health in gynecologic cancer.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:147-152.
    PubMed     Text format     Abstract available

  68. PUNTAMBEKAR S, Manchanda R
    Surgical pelvic anatomy in gynecologic oncology.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:86-92.
    PubMed     Text format     Abstract available

  69. GLASER G, Dowdy SC, Peedicayil A
    Enhanced recovery after surgery in gynecologic oncology.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:143-146.
    PubMed     Text format     Abstract available

  70. NGAN HYS, Seckl MJ, Berkowitz RS, Xiang Y, et al
    Update on the diagnosis and management of gestational trophoblastic disease.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:79-85.
    PubMed     Text format     Abstract available

  71. ARORA V, Somashekhar SP
    Essential surgical skills for a gynecologic oncologist.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:118-130.
    PubMed     Text format     Abstract available

  72. BOTHA MH, Rajaram S, Karunaratne K
    Cancer in pregnancy.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:137-142.
    PubMed     Text format     Abstract available

  73. BEREK JS, Kehoe ST, Kumar L, Friedlander M, et al
    Cancer of the ovary, fallopian tube, and peritoneum.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:59-78.
    PubMed     Text format     Abstract available

  74. LIN MY, Dobrotwir A, McNally O, Abu-Rustum NR, et al
    Role of imaging in the routine management of endometrial cancer.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:109-117.
    PubMed     Text format     Abstract available

  75. MAALOE N, Andersen CB, Housseine N, Meguid T, et al
    Effect of locally tailored clinical guidelines on intrapartum management of severe hypertensive disorders at Zanzibar's tertiary hospital (the PartoMa study).
    Int J Gynaecol Obstet. 2018 Oct 11. doi: 10.1002/ijgo.12692.
    PubMed     Text format     Abstract available


    JAMA

  76. PENG S, Li C, Sun X
    Glyburide vs Insulin for Gestational Diabetes.
    JAMA. 2018;320:1383-1384.
    PubMed     Text format    

  77. SENAT MV, Affres H, Bouyer J
    Glyburide vs Insulin for Gestational Diabetes-Reply.
    JAMA. 2018;320:1384.
    PubMed     Text format    

  78. CHEN H, Yang M, Lao L
    Acupuncture for Women Undergoing In Vitro Fertilization.
    JAMA. 2018;320:1385.
    PubMed     Text format    

  79. GU S
    Acupuncture for Women Undergoing In Vitro Fertilization.
    JAMA. 2018;320:1384-1385.
    PubMed     Text format    

  80. SMITH C
    Acupuncture for Women Undergoing In Vitro Fertilization-Reply.
    JAMA. 2018;320:1385-1386.
    PubMed     Text format    


    Lancet

  81. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed     Text format    


    Lancet Oncol

  82. JIE J, Niu W
    Common analgesics and ovarian cancer prognosis.
    Lancet Oncol. 2018;19:e505.
    PubMed     Text format    

  83. FAN G, Xu G, Zhang X
    Common analgesics and ovarian cancer prognosis.
    Lancet Oncol. 2018;19:e506.
    PubMed     Text format    

  84. MERRITT MA, Tworoger SS
    Common analgesics and ovarian cancer prognosis - Authors' reply.
    Lancet Oncol. 2018;19:e507.
    PubMed     Text format    


    Lancet Public Health

  85. BAUSSANO I, Bray F
    Modelling cervical cancer elimination.
    Lancet Public Health. 2018 Oct 1. pii: S2468-2667(18)30189.
    PubMed     Text format    

  86. HALL MT, Simms KT, Lew JB, Smith MA, et al
    The projected timeframe until cervical cancer elimination in Australia: a modelling study.
    Lancet Public Health. 2018 Oct 1. pii: S2468-2667(18)30183.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  87. SONALKAR S, Hunter T, Gurney EP, McAllister A, et al
    A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002926.
    PubMed     Text format     Abstract available

  88. WYMAN AM, Lafranchise E, Lynch C
    External Use of an Oxidized Regenerated Cellulose Agent in the Treatment of Labial Agglutination in Postmenopausal Women.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002919.
    PubMed     Text format     Abstract available

  89. GRESSEL GM, Turker L, Dioun SM, McGinn AP, et al
    Characterization of Risk Factors and Timing of Venous Thromboembolism in Patients With Uterine Serous Carcinoma.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002932.
    PubMed     Text format     Abstract available

  90. VITERI OA, Alrais MA, Pedroza C, Hutchinson M, et al
    Torsemide for Prevention of Persistent Postpartum Hypertension in Women With Preeclampsia: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002941.
    PubMed     Text format     Abstract available

  91. THAXTON L, Pitotti J, Espey E, Teal S, et al
    Nitrous Oxide Compared With Intravenous Sedation for Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002915.
    PubMed     Text format     Abstract available

  92. TRIVEDI S, Haddad LB, Narvaez J, Walker E, et al
    A Comprehensive Evaluation of Obstetrics and Gynecology Residencies' Global Health Training Programs.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002935.
    PubMed     Text format     Abstract available

  93. JORGENSEN EM, Li A, Modest AM, Leung K, et al
    Incidence of Venous Thromboembolism After Different Modes of Gynecologic Surgery.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002918.
    PubMed     Text format     Abstract available

  94. LIU JH, Soper D, Lukes A, Gee P, et al
    Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002942.
    PubMed     Text format     Abstract available

  95. SUH-BURGMANN E, Flanagan T, Osinski T, Alavi M, et al
    Prospective Validation of a Standardized Ultrasonography-Based Ovarian Cancer Risk Assessment System.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002939.
    PubMed     Text format     Abstract available

  96. GRECHUKHINA O, Deshmukh U, Fan L, Kohari K, et al
    Cesarean Scar Pregnancy, Incidence, and Recurrence: Five-Year Experience at a Single Tertiary Care Referral Center.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002940.
    PubMed     Text format     Abstract available

  97. STOCKDALE CK, Boardman L
    Diagnosis and Treatment of Vulvar Dermatoses.
    Obstet Gynecol. 2018;131:371-386.
    PubMed     Text format     Abstract available

  98. CARR BR, Stewart EA, Archer DF, Al-Hendy A, et al
    Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002933.
    PubMed     Text format     Abstract available

  99. BRETSCHNEIDER CE, Sheyn D, Pollard R, Ferrando CA, et al
    Complication Rates and Outcomes After Hysterectomy in Transgender Men.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002936.
    PubMed     Text format     Abstract available

  100. RUIZ MP, Chen L, Hou JY, Tergas AI, et al
    Effect of Minimum-Volume Standards on Patient Outcomes and Surgical Practice Patterns for Hysterectomy.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002912.
    PubMed     Text format     Abstract available

  101. WYATT MA, Ainsworth AJ, DeJong SR, Cope AG, et al
    Implementation of the "Pregnancy Reasonably Excluded Guide" for Pregnancy Assessment: A Quality Initiative in Outpatient Gynecologic Surgery.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002917.
    PubMed     Text format     Abstract available

  102. GARDNER B, Kozakiewicz ML, Whitecar PW, Nitsche JF, et al
    Novel Approach to Reduction of an Incarcerated Uterus.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002934.
    PubMed     Text format     Abstract available

  103. VAN NAGELL JR JR, Burgess BT, Miller RW, Baldwin L, et al
    Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002921.
    PubMed     Text format     Abstract available

  104. ROBERTSON SE, Peipert JF
    Ultrasound Screening for Ovarian Cancer: Are We There Yet?
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002962.
    PubMed     Text format    


    Oncogene

  105. YAMAGUCHI H, Du Y, Nakai K, Ding M, et al
    EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  106. CORKERY DP, Clarke LE, Gebremeskel S, Salsman J, et al
    Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
    Oncogene. 2018;37:174-184.
    PubMed     Text format     Abstract available

  107. MCLEAN K, Tan L, Bolland DE, Coffman LG, et al
    Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0523.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: